Pay in 4 interest-free payments of $28.38 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
orally-available
4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) induces CRISPR/Cas9 systems based on ER mediated nucleus translocation
Methods developed by different labs are tedious and unpractical
These cytokines may represent potential targets for immune-mediated inflammatory conditions or
In plant cells
Y-27632 Pack Size:5 mg orally-availableY 27632 is an orally active, ATP competitive inhibitor of ROCK I and ROCK II, with Kis of 220 and 300 nM, respectively. Y 27632 attenuates Doxorubicin induced apoptosis of human cardiac stem cells. Y 27632 also suppresses dissociation induced apoptosis of murine prostate stem progenitor cells. Y 27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial mesenchymal transition